Tag

Servier Announce Publication in the New England Journal of Medicine

7 minuti di lettura

Taiho Oncology and Servier Announce Publication in the New England Journal of Medicine of Pivotal Phase 3 Data for Trifluridine/Tipiracil (LONSURF®) in Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer

(Adnkronos) – PRINCETON, N.J. and PARIS, May 4, 2023 /PRNewswire/ — Taiho Oncology, Inc. and Servier today announced the publication of results from the pivotal Phase 3 SUNLIGHT* clinical trial of trifluridine/tipiracil

>>> vai all'articolo completo

Dove la notizia è solo l'inizio

Servier Announce Publication in the New England Journal of Medicine

Taiho Oncology and Servier Announce Publication in the New England Journal of Medicine of Pivotal Phase 3 Data for Trifluridine/Tipiracil (LONSURF®) in Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer

We Must Stop Attacks on Children Immediately

Emanuela Orlandi, rivelazione dell’ex carabiniere: “Sepolta sotto Castel Sant’Angelo”

Ucraina, guerra arriva in Russia: “Attacchi con armi e mezzi Usa”

Giulia Tramontano, i messaggi di Impagnatiello prima e dopo l’omicidio

Saviano e il “saluto romano a parata 2 giugno”: la replica di Crosetto

Suggerimenti

Servier Announce Publication in the New England Journal of Medicine

Taiho Oncology and Servier Announce Publication in the New England Journal of Medicine of Pivotal Phase 3 Data for Trifluridine/Tipiracil (LONSURF®) in Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer

We Must Stop Attacks on Children Immediately

Emanuela Orlandi, rivelazione dell’ex carabiniere: “Sepolta sotto Castel Sant’Angelo”

Ucraina, guerra arriva in Russia: “Attacchi con armi e mezzi Usa”

Giulia Tramontano, i messaggi di Impagnatiello prima e dopo l’omicidio

Saviano e il “saluto romano a parata 2 giugno”: la replica di Crosetto